亞輝龍(688575.SH):深創投及其一致行動人的合計持股比例減少至5%
格隆匯6月7日丨亞輝龍(688575.SH)公佈,此次權益變動後,深圳市創新投資集團有限公司(“深創投”)及其一致行動人深圳紅土醫療健康產業股權投資基金合夥企業(有限合夥)(“紅土醫療”)、深圳市紅土孔雀創業投資有限公司(“紅土孔雀”)、廣東紅土創業投資有限公司(“廣東紅土”)、深圳市坪山區紅土創新發展創業投資有限公司(“坪山紅土”),合計持有公司股份2835萬股,合計持股比例將從5.36%減少至5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.